Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-12-19

FDA Approved: CYTOTEC — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for Cytotec (misoprostol) from Pfizer Laboratories Div Pfizer Inc, resulting in a labeling update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cytotec (misoprostol)

Snippet

SUPPL AP for CYTOTEC (MISOPROSTOL)